- Home
- / T3 Pharmaceuticals
T3 Pharmaceuticals
Total Funding
$38.8 M
T3 Pharmaceuticals Summary
Company Summary
- Overview
- T3 Pharmaceuticals is a biopharmaceutical company developing therapies for cancer patients. It offers a proprietary technology that allows for protein delivery into eukaryotic cells using live bacteria.
- Type
- Private
- Status
- Active
- Founded
- 2015
- HQ
- Basel, CH | view all locations
- Website
- https://www.t3pharma.com/
- Cybersecurity rating
Table of Contents
Key People
Christoph A. Kasper, Chief Scientific Officer
Claire Barton, Chief Medical Officer
Olivier Valdenaire, Chairman of the Board of Directors
LocationsView all
1 location detected
Basel, BS HQ
Switzerland
Klingelbergstrasse 50